Sanjivani Paranteral Ltd. logo

Sanjivani Paranteral Ltd. (SANJIVIN)

Market Closed
11 Aug, 22:00
MSE MSE
194. 75
+6.8
+3.618%
1.8B Market Cap
- P/E Ratio
0.5% Div Yield
50 Volume
0 Eps
187.95
Previous Close
Add Transaction
Day Range
194.75 198
Year Range
126 268.8
Want to track SANJIVIN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SANJIVIN closed today higher at ₹194.75, an increase of 3.618% from yesterday's close, completing a monthly increase of 28.7178% or ₹43.45. Over the past 12 months, SANJIVIN stock lost -14.207%.
SANJIVIN pays dividends to its shareholders, with the most recent payment made on Oct 26, 2025. The next estimated payment will be in 9 months ago on Oct 26, 2025 for a total of ₹0.5.
The last earnings report, released on May 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.736%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

SANJIVIN Chart

People also search for

Rainbow Foundations Ltd.
38.35
-2.9114%
Flexituff Ventures International Limited
3.42
-4.2017%
Pondy Oxides And Chemicals Limited
492
+1.7791%
UCAL Ltd.
120
+0.798%
Shahlon Silk Industries Ltd.
23.99
+0.7983%

Sanjivani Paranteral Ltd. (SANJIVIN) FAQ

What is the stock price today?

The current price is ₹194.75.

On which exchange is it traded?

Sanjivani Paranteral Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is SANJIVIN.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.5%.

What is its market cap?

As of today, the market cap is 1.8B.

Has Sanjivani Paranteral Ltd. ever had a stock split?

No, there has never been a stock split.

Sanjivani Paranteral Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Ashwani A. Khemka CEO
MSE Exchange
INE860D01013 ISIN
India Country
40 Employees
19 Sep 2025 Last Dividend
- Last Split
- IPO Date

Overview

Sanjivani Paranteral Limited is a distinguished pharmaceutical company that has marked its presence both in India and on the international front. Incorporated in 1994, the company is strategically headquartered in Mumbai, India. It is renowned for manufacturing and distributing a wide range of pharmaceutical products that cater to various therapeutic areas. Sanjivani Paranteral Limited operates with the core aim of improving patient care and health outcomes by providing high-quality medication. It has built a reputable standing in the pharmaceutical industry, especially known for its excellence in producing oral solids, small volume parenterals, and sterile powder formulations. The company is also a key supplier to crucial healthcare institutions, including army hospitals, railway hospitals, ESIC hospitals, and others, ensuring a wide accessibility of its products to those in dire need.

Products and Services

  • Antibiotic: The company manufactures a range of antibiotics used to combat bacterial infections, offering both broad-spectrum and targeted solutions.
  • Anti-emetic: These products are developed to prevent nausea and vomiting caused by various conditions and treatments, such as chemotherapy.
  • Anti-tuberculosis: Specialized products designed to treat tuberculosis, a critical health concern in many countries, including India.
  • NSAID and Analgesic: Nonsteroidal anti-inflammatory drugs and analgesics are provided for relieving pain, reducing inflammation, and lowering fever.
  • Anti-diabetic: Medications aimed at controlling diabetes by either increasing insulin sensitivity or altering the production and release of insulin.
  • Anti-malarial: Products focus on the prevention and treatment of malaria, a major issue in tropical and subtropical regions.
  • Anti-fungal: These formulations are intended to treat fungal infections, ranging from superficial skin conditions to systemic infections.
  • Calcium and Vitamin: Supplements to aid in the prevention of deficiencies or certain conditions caused by low levels of vitamins or calcium.
  • Anti-convulsant: Medications designed to prevent or reduce the frequency of seizures in various types of epilepsy and other conditions.
  • Multi Vitamin: Comprehensive vitamin supplements designed to support general health and wellbeing.
  • Sedative: Products aimed at inducing calmness, reducing stress, or aiding sleep.
  • Steroid: Steroidal medications for anti-inflammatory and immunosuppressant purposes.
  • Cardiovascular: A range of medications targeting heart diseases and conditions, including hypertension and heart failure.
  • Cold: Formulations designed to alleviate symptoms of the common cold, including congestion and cough.
  • Proton Pump Inhibitor and H: Medications focusing on reducing stomach acid production to treat conditions like GERD and ulcers.
  • Ergot Alkaloid: Drugs derived from ergot, a type of fungus, used for various medical conditions, including migraines and certain vascular diseases.
  • Anti-coagulant: Medications that help prevent blood clots, vital in treating or preventing conditions like deep vein thrombosis and pulmonary embolism.
  • Anti-gout: Products designed to treat gout, a form of arthritis characterized by severe pain, redness, and tenderness in joints.
  • Anti-viral: Medications aimed at treating viral infections, including those caused by influenza, herpes, and other viruses.
  • Anti-fibrinolytic: Drugs that prevent the breakdown of blood clots, used in conditions where there's excessive bleeding.
  • Erectile Dysfunction: Products aimed at treating erectile dysfunction, enhancing sexual performance and satisfaction.
  • Anti-motility: Medications designed to reduce the speed of gastrointestinal movement, used in treating diarrhea and similar conditions.

Contact Information

Address: 1202, B-Wing
Phone: 91 22 2081 2600